Description
Bronchogen is a research peptide composed of the amino acids Ala-Glu-Asp-Leu (AEDL). It’s classified as a bioregulator, specifically targeting the broncho-pulmonary system. Research suggests Bronchogen can stimulate reparative processes in bronchial cells, potentially improving lung function and reducing inflammation. Studies conducted on rat models indicate that Bronchogen can reduce inflammation and restore healthy lung tissue by influencing multiple DNA transcription pathways. Overall, Bronchogen enhances the lung epithelium, boosts surfactant production, and diminishes inflammation. Current research is exploring Bronchogen’s potential benefits not only for lung diseases but also for aging. It seems that Bronchogen has geroprotective properties, aiding in the reversal of age-related lung function decline by reactivating senescent DNA. Additionally, this peptide may help uncover the mechanisms that protect against lung cancer development.
